Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2011

View Archived Issues

Supernus Pharma reports on phase IIa trial of SPN-812 in adults with ADHD

ChronTech initiates phase IIb trial of its HCV DNA vaccine with Inovio's MedPulser delivery device

First oral LH receptor agonist induces ovulation in healthy women

Phase I trial of E-3810 under way in patients with advanced cancer

AZ-13 and AZ-78 reduce beta-amyloid production in vitro and in vivo

Array BioPharma and Genentech prepare new B-raf inhibitors

Georgetown University investigators design novel apoptosis inducers

Marina Biotech begins phase Ib/IIa trial of oral CEQ-508 in familial adenomatous polyposis

Simcere files IND in China for APX-003

New radiolabeled polypeptide bioconjugates presented as agents to image apoptosis

New tetrahydroisoquinoline derivatives for cancer patented by University of Tennessee

Omthera Pharma raises funds for phase III Epanova trial

Transcept Pharma begins phase II TO-2061 trial in obsessive-compulsive disorder

Biothera begins phase I/II trial of Imprime PGG in chronic lymphocytic leukemia

Phase II trial of PD-0332991 advances in patients with KRAS-mutant colorectal cancer

Lantheus Medical Imaging and FDA agree on SPA for phase III flurpiridaz F 18 trial

Impax discloses topline data from phase III ADVANCE-PD trial of IPX-066

Teysuno approved in E.U. for advanced gastric cancer

Repligen's phase III study of RG-1068 in pancreatic imaging meets coprimary endpoints

Cerenis begins phase II CHI-SQUARE trial of CER-001 in patients with ACS

Interim phase I data support safety and promising activity of namitecan in solid tumors

Meiji Seika and RaQualia enter into license agreement for ziprasidone in Japan

FDA approves Bayer's contrast agent Gadavist for MRI of the CNS

Pivotal COMFORT-II study of Incyte's ruxolitinib meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...